Wintrobe Hematology Chronic Myeloid Leukemia cytogenetic, and molecular remissions in the majority of patients. The distinction between complete hematologic response (CHR), complete cytogenetic response (CCyR), and major molecular response (MMR) is critical for long-term disease control. However, resistanc Jul 18, 2026 Read more →
Hairy Cell Leukemia A Rare Case Report ment, offering high rates of durable remission. Current Therapeutic Approaches Purine Nucleoside Analogues: Cladribine remains the frontline therapy, 1. achieving complete remission in over 80% of patients. Its administration is typically a single 5- to 7-day cour Dec 9, 2025 Read more →
